{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04903223",
            "orgStudyIdInfo": {
                "id": "STUDY00001550"
            },
            "organization": {
                "fullName": "Children's Mercy Hospital Kansas City",
                "class": "OTHER"
            },
            "briefTitle": "Liver Adiposity Effects on Pediatric Statin",
            "officialTitle": "Effects of Pediatric Liver Adiposity on Statin Disposition and Response",
            "therapeuticArea": [
                "Other"
            ],
            "study": "liver-adiposity-effects-on-pediatric-statin"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-04-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-17",
            "studyFirstSubmitQcDate": "2021-05-22",
            "studyFirstPostDateStruct": {
                "date": "2021-05-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-02",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jon Wagner",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Children's Mercy Hospital Kansas City"
            },
            "leadSponsor": {
                "name": "Children's Mercy Hospital Kansas City",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "Single center, open-label, prospective investigation to quantify the effects hepatocellular fat has on hepatic statin transport and response in children and adolescents in obese and non-obese children and adolescents 8-21 years of age with normal, wild-type SLCO1B1 c.521TT genotype that are dosed rosuvastatin"
        },
        "conditionsModule": {
            "conditions": [
                "Cholesterol; Lipidosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "This is a single center, open-label, prospective, investigation to quantify the effects hepatocellular fat has on hepatic statin transport (SA1) and response (SA2) in children and adolescents.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Baseline Mevalonate and MRI Imaging",
                    "type": "NO_INTERVENTION"
                },
                {
                    "label": "Mevalonate Change After Rosuvastatin",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: Rosuvastatin 10mg"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Rosuvastatin 10mg",
                    "description": "Rosuvastatin will be administered to all participants on Study Day #2",
                    "armGroupLabels": [
                        "Mevalonate Change After Rosuvastatin"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Evaluate effect of Liver Fat Percentage (on MRI) on AUC",
                    "description": "We expect that increased liver adiposity will be associated with higher systemic statin exposure and thus, place those with higher liver adiposity fraction at increased risk for drug toxicity.",
                    "timeFrame": "2 years"
                },
                {
                    "measure": "Evaluate effect of Liver Fat Percentage (on MRI) on change on plasma mevalonate level",
                    "description": "We expect that increased liver adiposity will be associated with an attenuated mevalonate response to a statin in obese children placing those with increased liver adiposity at risk for treatment failure.",
                    "timeFrame": "2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 8-21 years\n* LDL cholesterol \\>130mg/dl (\\>95% percentile)\n* SLCO1B1 c.521TT genotype\n* Provide informed permission-assent(\\<18 yrs.) or consent (\u226518 yrs.)\n* Fasting overnight (\\~8 hrs.)\n* Enrolled in Cardiology Pharmacogenomic Repository\n\nExclusion Criteria:\n\n* Pregnancy\n* Non-fasting\n* Non-removable metal in body or MRI unsafe\n* Currently on statin therapy and unwilling to wash out of statin therapy for at least 4 weeks prior to Visit 1 and throughout the duration of the study.\n* Underlying unrepaired congenital or acquired cardiovascular defects or repaired congenital or acquired cardiovascular defects with hemodynamically significant residual disease.\n* History of underlying or laboratory evidence of underlying intestinal, metabolic, autoimmune, renal disease that can alter rosuvastatin disposition\\* (absorption, metabolism, distribution, or clearance)\n* Pharmacotherapy that interacts with statins (OATP1B1 inducers/inhibitors) \\*\n* Inability to swallow a tablet\n* \\>5x the age-specific upper limit of normal for AST, ALT, total and conjugated bilirubin\n* Diarrhea in the last 24 hours\n* Anything that would exclude a participant from completing an MRI, such as pacemakers, claustrophobia, or body habitus (e.g., weight greater than 350 lbs.)",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "8 Years",
            "maximumAge": "21 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jonathan Wagner, DO",
                    "role": "CONTACT",
                    "phone": "816-731-7240",
                    "email": "jbwagner@cmh.edu"
                },
                {
                    "name": "Jazzie K Holliday",
                    "role": "CONTACT",
                    "phone": "816-302-3500",
                    "email": "jkholliday@cmh.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Children's Mercy Hospital",
                    "status": "RECRUITING",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64108",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jonathan B Wagner, DO",
                            "role": "CONTACT",
                            "phone": "816-234-3000",
                            "phoneExt": "59373",
                            "email": "jbwagner@cmh.edu"
                        },
                        {
                            "name": "Jonathan B Wagner, DO",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008064",
                    "term": "Lipidoses"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008052",
                    "term": "Lipid Metabolism, Inborn Errors"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000052439",
                    "term": "Lipid Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "relevance": "LOW"
                },
                {
                    "id": "M11064",
                    "name": "Lipidoses",
                    "asFound": "Lipidosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M11054",
                    "name": "Lipid Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27029",
                    "name": "Lipid Metabolism Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068718",
                    "term": "Rosuvastatin Calcium"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000924",
                    "term": "Anticholesteremic Agents"
                },
                {
                    "id": "D000000960",
                    "term": "Hypolipidemic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000057847",
                    "term": "Lipid Regulating Agents"
                },
                {
                    "id": "D000019161",
                    "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M298",
                    "name": "Rosuvastatin Calcium",
                    "asFound": "Limb",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11110",
                    "name": "Liver Extracts",
                    "relevance": "LOW"
                },
                {
                    "id": "M21155",
                    "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M4243",
                    "name": "Anticholesteremic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4278",
                    "name": "Hypolipidemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M28883",
                    "name": "Lipid Regulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Lipd",
                    "name": "Lipid Regulating Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Hemat",
                    "name": "Hematinics"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}